PCG
Private Capital Group Portfolio holdings
AUM
$133M
1-Year Est. Return
11.23%
1 Year Est. Return
-11.23%
AUM
$133M
AUM Growth
-$308M
(-70%)
Holding
2,258
Top Buys
| 1 | +$89.9K | |
| 2 | +$89.8K | |
| 3 | +$74.5K | |
| 4 |
Monolithic Power Systems
MPWR
|
+$73.1K |
| 5 |
Microchip Technology
MCHP
|
+$61.6K |
Top Sells
| 1 | +$25.7M | |
| 2 | +$18.2M | |
| 3 | +$13.5M | |
| 4 |
Vanguard Mid-Cap Growth ETF
VOT
|
+$12.4M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$9.46M |
Sector Composition
| 1 | Technology | 13.81% |
| 2 | Financials | 8.52% |
| 3 | Healthcare | 8.17% |
| 4 | Consumer Discretionary | 5.98% |
| 5 | Industrials | 5.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Innovator S&P Investment Grade Preferred ETF
EPRF
$79.8M
| – | – |
-300
|
|
||
1902
iShares MSCI USA Equal Weighted ETF
EUSA
$1.41B
| – | – |
-5,789
|
|
||
1903
iShares ESG Advanced Universal USD Bond ETF
EUSB
$681M
| – | – |
-3,017
|
|
||
1904
EverCommerce
EVCM
$1.59B
| – | – |
-103
|
|
||
1905
Edgewise Therapeutics
EWTX
$2.67B
| – | – |
-151
|
|
||
1906
Fate Therapeutics
FATE
$122M
| – | – |
-18
|
|
||
1907
Fortress Biotech 9.375% Series A Preferred Stock
FBIOP
$24.1M
| – | – |
-135
|
|
||
1908
First Bancorp
FNLC
$289M
| – | – |
-291
|
|
||
1909
Fox Class A
FOXA
$29.6B
| $0 | ﹤0.01% |
2
|
|